METASTATIC KIDNEY MEDULLARY CARCINOMA
Clinical trials for METASTATIC KIDNEY MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC KIDNEY MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC KIDNEY MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for aggressive, rare kidney cancer
Disease control OngoingThis study is testing whether adding a new drug called ixazomib to two standard chemotherapy drugs works better for controlling an aggressive type of kidney cancer that has spread. It is for patients aged 12 and older whose cancer has progressed after other treatments and who hav…
Matched conditions: METASTATIC KIDNEY MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Immunotherapy tested as new hope for rare, Tough-to-Treat cancers
Disease control OngoingThis study tested whether the immunotherapy drug pembrolizumab could help control the growth of rare, advanced cancers that have spread or cannot be removed by surgery. It involved 157 patients with specific rare tumor types who had already tried standard treatments. The goal was…
Matched conditions: METASTATIC KIDNEY MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC